Guidance

Sickle cell and thalassaemia screening: information for fathers

Leaflet for expectant fathers explaining antenatal screening for sickle cell and thalassaemia.

• From: Public Health England
• Published: 1 January 2012
• Last updated: 2 December 2021 — See all updates

Documents

Information for fathers invited for a screening test for sickle cell disease and thalassaemia major

Ref: PHE publications gateway number: GW-973

HTML

Information for fathers invited for a screening test for sickle cell disease and thalassaemia major (for print)

PDF, 254 KB, 4 pages

Details

This publication for fathers-to-be explains antenatal screening for sickle cell and thalassaemia.

Services should signpost fathers to this information where antenatal screening shows the expectant mother is a carrier for sickle cell, thalassaemia or another haemoglobin variant. It describes:

• haemoglobin disorders
• the screening test
• the range of possible results
• the possible risks of the baby inheriting a condition
• the choices that the baby’s parents can make

This information is available in A4 PDF format (in English) to print out and provide for people who cannot access digital information. For more information, see the ‘order printed leaflets’ section of our guidance on how to access and order leaflets.

Contact the PHE Screening helpdesk with any queries about this publication, making sure you include its full title.

Published 1 January 2012
Last updated 2 December 2021 + show all updates

1. 2 December 2021

   Added plain A4 PDF version for printing, to provide for people unable to access this information online.

2. 15 February 2021

   Minor change to wording on the use of personal information.

3. 10 January 2020

   Added HTML version of SCT screening information for fathers.

4. 29 March 2018

   Added use of personal data statement.

5. 8 August 2017

   Updated version of public information leaflet.

6. 11 April 2017

   Updated version of leaflet.

7. 1 January 2012

   First published.